Development and validation of a predictive score to identify K-Ras wild-type (WT) metastatic colorectal cancer (mCRC) patients who are likely to benefit from Panitumumab (P) treatment. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback